Natera Announces First Quarter 2019 Earnings Conference Call

SAN CARLOS, Calif., May 2, 2019 /PRNewswire/ -- Natera, Inc. NTRA, a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today announced that it will release results for its first quarter ended March 31, 2019, after the market close on May 9, 2019. Natera will host a conference call and webcast at 1:30 p.m. PT (4:30 p.m. ET) to discuss its financial results, business activities, and financial outlook.

A webcast replay will be available at investor.natera.com.

About Natera
Natera is a global leader in cell-free DNA testing. The mission of the company is to transform the diagnosis and management of genetic diseases. Natera operates an ISO 13485-certified and CAP-accredited laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, Calif. It offers a host of proprietary genetic testing services to inform physicians who care for pregnant women, researchers in cancer including biopharmaceutical companies, and genetic laboratories through its cloud-based software platform. Follow Natera on LinkedIn and Twitter.

Contacts
Investor Relations
Mike Brophy, CFO, Natera, 650-249-9090
Media
Andrea Sampson, Sullivan & Sampson, 714-374-6174, asampson@sullivanpr.com

SOURCE Natera